Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 29, 2011

Potential New Treatment for Multiple Sclerosis

  • MS Research Study and Reports
    /
RedOrbit.com Posted on: Tuesday, 29 March 2011,  (Ivanhoe Newswire) – Multiple Sclerosis (MS) is a common, and usually disabling autoimmune…
MS Research Study and Reports

March 29, 2011

Report Identifies Cluster areas for MS in Ohio

  • MS Research Study and Reports
    /
Wellington has been designated as a disease cluster area for multiple sclerosis, according to a report released yesterday by the…
MS Research Study and Reports

March 29, 2011

The ‘MS Views & News’ – Online Charity Auction Series

  • Misc. MS Related
    /
  • Stu's Views and MS News
    /
March 29. 2011 Dear Friends, As you know, MS Views and News, Inc. is dedicated to the global collection and…
Misc. MS Related

March 27, 2011

Down and Dirty to raise money at the annual Mud Run MS in Jacksonville

  • Multiple Sclerosis
    /
  • National MS Society Related
    /
March 26, 2011 – By Matt Soergel There comes a time in every Mud Run when simply splashing through thick brown…
Multiple Sclerosis

March 26, 2011

Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
THE WOODLANDS, Texas (March 23, 2011) – Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing a novel T-cell therapy for multiple sclerosis…
MS Drug Therapies

March 26, 2011

Novartis’s Gilenya MS Pill to Cost EU22,000 a Year in Germany

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
By Eva von Schaper – Mar 25, 2011 Novartis AG (NOVN)’s multiple sclerosis pill Gilenya will cost 1,850 euros ($2,620) a month in…
MS Drug Therapies

March 26, 2011

Sativex recommended for approval in six European countries to treat multiple sclerosis

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Barcelona, Spain Friday, March 25, 2011,  GW Pharmaceuticals plc (AIM:GWP) and Almirall S.A. (ALM) announce the successful completion of the…
Alternative therapies and devices for Multiple Sclerosis (MS)

March 26, 2011

Bellingham man with MS scales Mount Baker, helps others cope with the disease

  • An MS Patients Story
    /
  • Multiple Sclerosis
    /
March 25, 2011 To look at lifelong athlete Keith Terry, who climbed Mount Baker last year on his first try,…
An MS Patients Story

March 26, 2011

A parent’s multiple sclerosis can take heavy toll on children

  • An MS Patients Story
    /
  • Caregiver related
    /
  • Multiple Sclerosis
    /
By Petula Dvorak, Thursday, March 24, 7:09 PM Alice is a 19-year-old woman who blogs anonymously about changing her mother’s diapers. She lies to people about…
An MS Patients Story

March 22, 2011

Novartis Receives European Commission Approval For Gilenya(R), The First Oral Multiple Sclerosis Treatment For Use In The EU

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
March 22, 2011 The European Commission has granted Novartis approval for Gilenya® (fingolimod) 0.5 mg daily as a disease modifying…
MS Drug Therapies

Categories

Latest Blog Posts